Clinical Trial: Serum Talin-1 and Cripto-1 in Colorectal Cancer

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414082) titled 'Serum Talin-1 and Cripto-1 in Colorectal Cancer' on Jan. 24.

Brief Summary: The goals of this study are

* To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.

* To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA

Study Start Date: March 30

Study Type: INTERVENTIONAL

Condition: Colo-rectal Cancer

Intervention: DIAGNOSTIC_TEST: Serum level of Human Talin-1

To evaluate the clinical utility of Talin-1 measurement in colorectal cancer patients in comparison with healthy controls.

DIAGNOSTIC_TE...